search
Back to results

Comparison of Two High Performance Guidewires in ERCP

Primary Purpose

Stenosis of Bile Duct

Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
VisiGlide™ angled tip
VisiGlide2™ angled tip
VisiGlide™ straight tip
VisiGlide2™ straight tip
Sponsored by
Johann Wolfgang Goethe University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Stenosis of Bile Duct focused on measuring stenosis, bile duct, guidewire, ercp

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Obstruction of the biliary tract (cross sectional imaging or ultrasonography/lab data

Exclusion Criteria:

  • Operatively alternated anatomy of the patient

Sites / Locations

  • Goethe University Hospital Frankfurt

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm Type

Active Comparator

Active Comparator

Active Comparator

Active Comparator

Arm Label

guidewire type 1: VisiGlide™ angled tip

guidewire type 2: VisiGlide2™ angled tip

guidewire type 1: VisiGlide™ straight tip

guidewire type 2: VisiGlide2™ straight tip

Arm Description

Primary use of VisiGlide™ guidewire (angled tip). In case it should not be possible to complete one step toward the therapeutic goal after 8 to max. 12 minutes after start of the examination, the wire system is changed: primary change to VisiGlide™ (straight tip) resp. to VisiGlid2e™ (tip according to the examiner)

Primary use of VisiGlide2™ guidewire (straight tip). In case it should not be possible to complete one step toward the therapeutic goal after 8 to max. 12 minutes after start of the examination, the wire system is changed: primary change to VisiGlide2™ (angled tip) resp. to VisiGlide™ (tip according to the examiner)

Primary use of VisiGlide™ guidewire (straight tip). In case it should not be possible to complete one step toward the therapeutic goal after 8 to max. 12 minutes after start of the examination, the wire system is changed: primary change to VisiGlide™ (angled tip) resp. to VisiGlide2™ (tip according to the examiner)

Primary use of VisiGlide2™ guidewire (straight tip). In case it should not be possible to complete one step toward the therapeutic goal after 8 to max. 12 minutes after start of the examination, the wire system is changed: primary change to VisiGlide2™ (angled tip) resp. to VisiGlide™ (tip according to the examiner)

Outcomes

Primary Outcome Measures

Number of successful passages of bilary (pancreatic) stenosis with the different guidewires.

Secondary Outcome Measures

Duration of ERCP session
Comparison of time needed for the ERCP session in all study groups

Full Information

First Posted
June 13, 2016
Last Updated
May 11, 2022
Sponsor
Johann Wolfgang Goethe University Hospital
Collaborators
Klinikum Stadt Hanau, Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor, Robert Bosch Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT03638700
Brief Title
Comparison of Two High Performance Guidewires in ERCP
Official Title
Comparison of the Use of Two High Performance Guidewires in Patients With Stenosis of the Bile Ducts in ERCP: A Randomised Multicenter Trial
Study Type
Interventional

2. Study Status

Record Verification Date
May 2022
Overall Recruitment Status
Completed
Study Start Date
May 2016 (undefined)
Primary Completion Date
October 2019 (Actual)
Study Completion Date
January 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Johann Wolfgang Goethe University Hospital
Collaborators
Klinikum Stadt Hanau, Institutul Regional de Gastroenterologie & Hepatologie Prof. dr. Octavian Fodor, Robert Bosch Medical Center

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
In ERCP guidewires are used for the insertion of endoprostheses and the cannulation of stenosis. This leads to two essential requirements for the wire systems: The use of a (highly) flexible, hydrophilic wire to achieve successful and rapid passage of the narrow passage; for additional intervention, modern wires are equipped with a stable shaft with which e.g. bougies, dilatation catheters, or stents can be introduced. Guidewires are available with angled or straight tips whose use differ regionally. Guidewires with angled tips are used predominantly in Japan, whereas in the Western world incl. Germany straight wires are commonly used. In a recently published study examining the intubation of the native papilla, successful intubation of the papilla was faster with guidewires with angled tips than with guidewires with straight tips. However, this did not result in an effect upon the time-independent rate of the successful papilla intubation. The investigators test the hypothesis that 1) a higher success rate of the ERCP can be achieved with the use of an angled guidewire than with a straight guidewire and 2) a higher success rate of the ERCP can be achieved with the use of a type 1 guidewire than with a type 2 guidewire
Detailed Description
This is a randomized, multicentric study.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Stenosis of Bile Duct
Keywords
stenosis, bile duct, guidewire, ercp

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
453 (Actual)

8. Arms, Groups, and Interventions

Arm Title
guidewire type 1: VisiGlide™ angled tip
Arm Type
Active Comparator
Arm Description
Primary use of VisiGlide™ guidewire (angled tip). In case it should not be possible to complete one step toward the therapeutic goal after 8 to max. 12 minutes after start of the examination, the wire system is changed: primary change to VisiGlide™ (straight tip) resp. to VisiGlid2e™ (tip according to the examiner)
Arm Title
guidewire type 2: VisiGlide2™ angled tip
Arm Type
Active Comparator
Arm Description
Primary use of VisiGlide2™ guidewire (straight tip). In case it should not be possible to complete one step toward the therapeutic goal after 8 to max. 12 minutes after start of the examination, the wire system is changed: primary change to VisiGlide2™ (angled tip) resp. to VisiGlide™ (tip according to the examiner)
Arm Title
guidewire type 1: VisiGlide™ straight tip
Arm Type
Active Comparator
Arm Description
Primary use of VisiGlide™ guidewire (straight tip). In case it should not be possible to complete one step toward the therapeutic goal after 8 to max. 12 minutes after start of the examination, the wire system is changed: primary change to VisiGlide™ (angled tip) resp. to VisiGlide2™ (tip according to the examiner)
Arm Title
guidewire type 2: VisiGlide2™ straight tip
Arm Type
Active Comparator
Arm Description
Primary use of VisiGlide2™ guidewire (straight tip). In case it should not be possible to complete one step toward the therapeutic goal after 8 to max. 12 minutes after start of the examination, the wire system is changed: primary change to VisiGlide2™ (angled tip) resp. to VisiGlide™ (tip according to the examiner)
Intervention Type
Device
Intervention Name(s)
VisiGlide™ angled tip
Intervention Description
Arm A: Primary use of VisiGlide™ guidewire (angled tip). In case it should not be possible to complete one step toward the therapeutic goal after 8 to max. 12 minutes after start of the examination, the wire system is changed: primary change to VisiGlide™ (straight tip) resp. to VisiGlid2e™ (tip according to the examiner)
Intervention Type
Device
Intervention Name(s)
VisiGlide2™ angled tip
Intervention Description
Arm B: Primary use of VisiGlide2™ guidewire (angled tip). In case it should not be possible to complete one step toward the therapeutic goal after 8 to max. 12 minutes after start of the examination, the wire system is changed: primary change to VisiGlide2™ (straight tip) resp. to VisiGlide™ (tip according to the examiner)
Intervention Type
Device
Intervention Name(s)
VisiGlide™ straight tip
Intervention Description
Arm C: Primary use of VisiGlide™ guidewire (straight tip). In case it should not be possible to complete one step toward the therapeutic goal after 8 to max. 12 minutes after start of the examination, the wire system is changed: primary change to VisiGlide™ (angled tip) resp. to VisiGlide2™ (tip according to the examiner)
Intervention Type
Device
Intervention Name(s)
VisiGlide2™ straight tip
Intervention Description
Arm D: Primary use of VisiGlide2™ guidewire (straight tip). In case it should not be possible to complete one step toward the therapeutic goal after 8 to max. 12 minutes after start of the examination, the wire system is changed: primary change to VisiGlide2™ (angled tip) resp. to VisiGlide1™ (tip according to the examiner)
Primary Outcome Measure Information:
Title
Number of successful passages of bilary (pancreatic) stenosis with the different guidewires.
Time Frame
through study completion, an average of 2 years
Secondary Outcome Measure Information:
Title
Duration of ERCP session
Description
Comparison of time needed for the ERCP session in all study groups
Time Frame
through study completion, an average of 2 years

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Obstruction of the biliary tract (cross sectional imaging or ultrasonography/lab data Exclusion Criteria: Operatively alternated anatomy of the patient
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jörg G Albert
Organizational Affiliation
Robert Bosch Krankenhaus Stuttgart, Germany
Official's Role
Principal Investigator
Facility Information:
Facility Name
Goethe University Hospital Frankfurt
City
Frankfurt
State/Province
Hessen
ZIP/Postal Code
60590
Country
Germany

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Comparison of Two High Performance Guidewires in ERCP

We'll reach out to this number within 24 hrs